One-anastomosis Gastric Bypass/Mini-Gastric Bypass Versus Roux-en Y Gastric Bypass
Launched by SANA KLINIKUM OFFENBACH · Feb 5, 2017
Trial Information
Current as of May 10, 2025
Terminated
Keywords
ClinConnect Summary
OAGB/MGB is gaining popularity as a primary surgical treatment for morbid obesity due to reduced operation time, a shorter learning curve, better weight loss, higher metabolic impact and fewer major complications compared to RYGB.
In this prospective randomized controlled trial we want to compare OAGB/MGB and RYGB with a FU of up to 24 month.
Patients with indication for gastric bypass get randomized in group A (RYGB, n = 50) or B (OAGB/MGB, n = 50). FU is performed 1, 3, 6, 12 and 24 month after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. primary obesity surgery and indication for gastric bypass
- • 2. age: 18 - 65 years
- • 3. BMI \> 40 kg/m² or BMI \> 35 kg/m² with obesity related comorbidities
- • 4. informed consent
- Exclusion Criteria:
- • 1. obesity surgery in the anamnesis
- • 2. visceral surgery in the anamnesis (excluding appendectomy and cholecystectomy)
About Sana Klinikum Offenbach
Sana Klinikum Offenbach is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. As a prominent sponsor of clinical trials, the hospital is committed to fostering innovation in treatment methodologies and enhancing patient outcomes through rigorous scientific investigation. With a multidisciplinary team of experienced healthcare professionals and state-of-the-art facilities, Sana Klinikum Offenbach prioritizes patient safety and ethical standards while contributing to the development of new therapies across various medical fields. The institution's collaborative approach integrates clinical expertise with research initiatives, making it a pivotal player in the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Offenbach, Hessen, Germany
Patients applied
Trial Officials
Sonja Chiappetta, MD
Study Chair
Sana Klinikum Offenbach
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials